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Summary: A new method for the quantitative determination of the cholesterol content of serum lipoproteins is
described. Electrophoresis of the serum lipoproteins on agarose gel is followed by the enzymatic determination of
the lipoprotein cholesterol. The cholesterol is released from the agarose pieces containing the lipoproteins by dissolv-
ing the agarose with HC1. No influence of the HC1 on cholesterol, and no influence of the agarose degradation pro-
ducts on the enzyme reactions was observed. The analytical procedure is simple and only 20 //I serum are required.
The average coefficient of variation for the determination of the /3-lipoprotein cholesterol is < 4%, and it is < 8% in
the pre-/Mipoproteins of Type IV hyperlipidemic patients. The cholesterol contents found in the other lipoprotein
fractions have to be interpreted as an approximation. Semiautomation seems to be possible.
In preliminary studies, the cholesterol concentrations of the serum lipoproteins were determined in some control
subjects and in some hyperlipidemic patients. The results are in good agreement with data obtained by ultracentri-
fuge studies performed by other investigators.
The advantages of this new procedure and aspects of application are discussed.
Enzymatische Bestimmung von Cholesterin in Serum-Lipoproteinen
Zusammenfassung: Ein neues Verfahren zur quantitativen Bestimmung von Cholesterin in Serum-Lipoproteinen
wird beschrieben. Die Lipoproteine werden mittels Elektrophorese auf Agarosegel gewonnen und anschließend wird
der Cholesteringehalt enzymatisch bestimmt. — Durch Auflösen der Agarose in HC1 werden die Lipide und damit
auch das Cholesterin frei gesetzt. Die HC1 hat keinen meßbaren Einfluß auf das Cholesterinmolekül und die Agarose-
abbauprodukte interferieren nicht mit den Enzymreaktionen. Das Verfahren ist einfach und zeichnet sich durch einen
geringen Serumbedarf von 20 aus. Der durchschnittliche Variationskoeffizient beträgt für die Bestimmung des Cho-
lesteringehalts in den ß-Lipoproteinen < 4% und für die prä-frLipoproteine der Hyperlipidämieform Typ IV < 8%.
Die Cholesteringehalte der anderen Fraktionen sind Näherungswerte. Eine Adaptation an die Semiautomation scheint
möglich zu sein.
In vorläufigen Untersuchungen wurde der Cholesteringehalt in Serum-Lipoproteinen von einigen Kontrollpersonen
und einigen hyperlipidämischen Patienten ermittelt. Die Ergebnisse sind weitgehend mit Werten vergleichbar, welche
von anderen Autoren mittels Ultrazentrifugation und anschließender Cholesterinbestimmung erzielt wurden.
Die Vorteile dieses neuen Verfahrens und Anwendungsmöglichkeiten werden diskutiert.
Introduction
Epidemiologie, clinical, and biochemical studies indicate
that an elevated cholesterol content in the human blood
serum and, therefore, in the serum lipoproteins, is one
*) Presented at the meeting of the German, Austrian and Swiss
Societies of Clinical Chemistry, March, 16-18,1975, Fiei-
buig L Br., Germany, and at the Ninth International Con-
gress on Clinical Chemistry, July,13-18, 1975, Toronto,
Canada.
of the cumulative risk factors involved in the process of
atherogenesis and coronary heart disease. The determi-
nation of this cholesterol is widely used as a tool for pro-
gnosis, diagnosis, and therapy control.
The serum lipoproteins are usually prepared by ultra-
centrifugation followed by the determination of chol-
esterol (1-12). This method, although accepted to be
the reference method, is time consuming, and relatively
large amounts of serum are required. Furthermore, the
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availability of an ultracentrifuge is still restricted to
specialized laboratories and research centers. For large-
scale studies, more simple and rapid procedures were
developed for the fractionation of the serum lipoproteins,
such as precipitation (4,13-19), or as a formula for
the approximation of the cholesterol content in the
lipoproteins, especially in the /J-lipoproteins (5,10,20).
The separation of the serum lipoproteins by electro-
phoresis on agarose gel is more simple and smaller
amounts of serum are needed. These lipoprotein frac-
tions may be analyzed in different ways. After lyophili-
zation the lipids can be extracted by organic solvents
(21). Ashing the material can be followed by the deter-
mination of phospholipid phosphorus (22). Radioactive
samples such as [3H]cholesterol-labelled lipoproteins
can be measured by liquid scintillation spectrophoto-
metry (23, 24).
It was the purpose of the present study to combine
electrophoresis of the serum lipoproteins on agarose gel
(25,26) with the enzymatic determination of cholesterol
(27). The structure of the agarose gel is destroyed by HC1,
and, among the other lipids, cholesterol and cholesterol-
esters are released. After the neutralization of the samp-
les, the enzymatic determination of cholesterol can be
carried out.
Phenotyping of the lipoprotein pattern
For this purpose, the serum lipoproteins are separated by the
CORNiNG-EEL/IMA-micro-electrophoresis system. Only one
μ\ serum is needed, and the whole procedure is finished within
one hour. The lipids are stained with Oil red 0.
The different patterns of hyperlipidemia were classified accord-
ing to Fredrickson et ai. (28), and according to the recommenda-
tions of an expert committee of the World Health Organization
(29).
Separation of the lipoproteins
Lipoprotein electrophoresis on agarose gel using fresh human
serum is performed as described by Kahlke (25, 26), and as
recommended by the BOSCAMP-Comp. The following modifi-
cations are introduced:
1. 3.5 ml 8 g/1 agaiose gel are applied to one microscope slide;
2. two parts of serum and one part of 16 g/1 agarose gel, warmed
to 56°C, are mixed, and a very small amoiint of the stained
human albumin powder is added. 30 μΐ of this mixture are
applied with a micro-pipette to the groove of one agarose
block;
3. electrophoresis is carried out at 6 mA per sample during
90 minutes;
4. for fixation, the samples are exposed to 20 g/1 acetic acid for
10 minutes only; thereafter, they are washed with distilled
water for 5 minutes;
5. the pherograms are covered with wet filter paper and moisture
is evaporated under a warm air stream as long as the agarose
layer can be lifted from the slide, and the filter paper remains
slightly wet. This takes approximately 20-30 minutes.
Equipment
CORNING-EEL/IMA-micro-electrophoresis system (D-6300
Gie en) and BOSCAMP-microphor system (D-5503 Hersel).
Chemicals
SERVA, D-6900 Heidelberg: Barbital-sodium phosphate buffer,
0.05 mol/1, pH 8.2 (No. 38 185), 8 g/1 agarose gel (INSTANT-
GEL, No. A-08-82), human albumin stained with bromphenol
blue and vitamin B12 (No. 11 885).
BEHR1NG, D-3550 Marburg: Bovine albumin.
MERCK, D-6701 Darmstadt: Ethanol, methanol, cone, hydro-
chloric acid, acetic acid, (NH4)H2PO4, and (NH4)2HP04 (all
chemicals p.a.); sodium hydroxide, purissimum, Sudan black.
BOEHRINGER, D-6800 Mannheim: Catalase (1 g/50 ml) (No.
15 674), and Biochemica Test Combination Cholesterol (No.
15 738). The composition of the commercial solutions of this
Test Combination is as follows:
Solution 1: 0.6 mol/1 ammonium phosphate buffer, pH 7,
1.7 mol/1 methanol; > 700 kU/1 catalase.
Solution 2: 0.42 mol/1 acetylacetonc; 2.5 mol/1 methanol;
21 g/1 hydroxypolyethoxydodecane.
Solution 3: > 7 kU/1 cholesterol esterase.
Solution 4: > 4 kU/1 cholesterol oxidase.
Solution 5: For the determination of the total serum cholesterol
(27), a reaction mixture is prepared from 10 parts
of solution 1, 0.50 parts of solution 2, and 0.04
parts of solution 3.
Solution V: For the determination of the serum lipoprotein
cholesterol, a modified reaction mixture is pre-
pared from 10 parts of solution 1, 0.75 parts of
solution 2,0.06 parts of solution 3, 0.4 parts of
methanol, and 0.004 parts of the catalase pre-
paration.
Localization of the lipoproteins
After fixation, the lipoproteins become visible by opalescence.
In addition, the albumin band prestained with bromphenol blue
can serve for further orientation. Parallel pherograms can be
stained in the common way with Sudan black or with other
lipid stains, and the unstained fractions can be cut according
to the stained pattern.
Enzymatic determination of cholesterol in the presence
of agarose
Step 1
Agarose samples containing known amounts of serum chol-
esterol are transferred to centrifuge tubes. The agarose pieces
containing the lipoprotein fractions are rolled around a small
glas rod and they are also transferred together with this glass
rod to centrifuge tubes. In this stage the samples can be stored
at + 4°C for several days, if neccessary.
Step 2
0.3 ml cone. HC1 are added. The agarose is dissolved within
a few seconds by swirling the sample vigorously on a vibrator.
Immediately afterwards, the centrifuge tubes are transferred to
a cooling bath, prepared from ice water and sodium chloride.
Step 3,
0.2 ml of the saturated ammonium phosphate buffer, pH 7,
are added. Do not shake the samples!
Step 4
0.4 ml of the sodium hydroxide solution (300 g/1) are added.
Step 5
After 5 minutes, the samples are mixed carefully.
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Step 6
3.0 ml of solution V are added. Each tube is taken out im-
mediately from the cooling bath. The samples are mixed again
and incubated at 37°C for 30 minutes. Afterwards, they are
centrifuged at 3000 rpm for 15 minutes. One ml of this pre-
incubated mixture is used for the oxidase reaction:
Step 7
Preincubated mixture






The samples are mixed and incubated at 37°C for at least
60 minutes. They are cooled down to room temperature and
measured at 405 nm in semi-micro glass cuvettes (pathlength
1 cm), each sample against its own sample blank.
Determination of the serum triacylglycerols
The triacylglycerols (triglycerides) are determined enzymatically
by the BOEHRINGER, Mannheim "Test Combination Neutral
Fat (Triglycerides) and Glycerol".
Calculations
The percent distribution of the total serum cholesterol between
the lipoproteins is calculated: ΔΑ(α. + ρΓβ-0- + /Mipoproteins)
= 100%. The cholesterol concentration of each lipoprotein frac-
tion can be calculated by referring the corresponding percentage
to the total cholesterol content of the serum.
The data are expressed as χ ± sx (CV, %), where χ = mean
value, sx = standard deviation, CV = coefficient of variation
= precision in the series, η = number of experiments.
Results and Discussion
Principle
Cholesterol distributed in agarose gel can be determined
enzymatically with the modification according to
Roeschlau et al. (27). The agarose samples containing the
cholesterol are dissolved in cone. HC1. During this proce-
dure, the gel structure of the agarose is destroyed, and,
as in the hydrolysis of other polysaccharides or peptides
by HC1, partial hydrolysis of the galacto-polysaccharide
to agarobiose and galactose may occur, thereby releasing
the cholesterol. After neutralization, the enzymatic deter^
minatipn of cholesterol can be performed. This procedure
is suitable for the determination of the cholesterol moiety
of serum lipoprotein fractions separated by electro-
phoresis on agarose gel modified according to Kahlke
(25,26).
Dissolution of the agarose
After the dissolution of the agarose by HClj the samples
are cooled carefully. This step appears to be an impor-
tant factor in this procedure. .Saturated ammonium phos-
phate buffer is added in order to increase the buffer
capacity of the final system, and in order to dilute the
cone. HC1 before neutralization with the NaOH solu-
tion, it is advisible to allow the samples to equilibrate
with the surrounding temperature after the addition of
each solution. This last step prevents the formation of
brownish coloured degradation products of the agarose
which do not interfere with the enzyme reaction
but which do elevate the optical density of the sample
blanks.
Modification of the enzymatic determination of
cholesterol
Solution V is prepared by modifying the original solu-
tion 5 of the "Test Combination Cholesterol" (27) as
follows: Except for the buffer, the concentrations of
the respective constituents are elevated by the factor
1.5. This should compensate roughly for the dilution
caused by the large volume of the neutralized sample,
thereby approximating the optimal conditions for the
enzyme reactions.
After the addition of solution V to the neutralized
samples, the tubes are taken out from the cooling bath
immediately in order to avoid the precipitation of salts
present at high concentrations.
During the preincubation period prior to the addition
of the cholesterol oxidase, the agarose degradation
products are precipitated — probably by the organic
solvents present in the sample — and can be eliminated
by centrifugation. This can also be done after the incuba-
tion with the cholesterol oxidase; however, in this case,
the number of tubes to be centrifuged would be doubled
because each sample has its own blank.
Comparison of the modified method with the
original method
As compared to the original serum method (27), the
efficiency of the enzyme reaction in this modified
method is 97% (tab. 1). Accordingly, no relevant
influence of the HC1 on cholesterol as a substrate for
the cholesterol oxidase exists and there is no inter-
ference of the agarose degradation products with the
enzyme reactions. These results are consistent with data
obtained by studies on the influence of HC1 on the
Chromatographie properties of cholesterol (in prepa-
ration).
The linearity of the calibration curve for the modified
method is the same as in the original method. The
detection limit is found to be around 0.5 mmol/1 serum,
that is an average absorbance of 0.020 per sample. It is
planned to lower this detection limit by further modi-
fications.
These results confirm that cholesterol present in agarose
gel can be determined enzymatically and quantitatively.
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Tab. 1. Comparison of the modified method with the original
method for the determination of cholesterol (27).
In the modified method, agarose samples containing 5,
10 and 20 μΐ serum are dissolved in the HO. The volume
of the agarose pieces was estimated at about 100 μ\. The
procedure is described in the text. Number in paran-
thesis: coefficient of variation; number of experiments
= 10.
modified method original method




5 M! serum 0.044 ± 0.002 (4.5)
10 μΐ serum 0.090 ± 0.002 (2.2)
20 jul serum 0.181 ± 0,003 (1.6)
xO.8
5.02 ml
0.037 ± 0.001 (2.7)
0.074 ± 0.001 (1.4)







Determination of the lipoprotein cholesterol
The electrophoretic procedure described above results
in a sharp separation of the lipoproteins of 20 /d serum.
There is no overload of the agarose block. By the addi-
tion of the stained albumin as a powder, further dilution
of the serum is avoided.
Under standardized experimental conditions, involving
fixation for exactly 10 minutes and drying as long as
the agarose layer can be lifted from the microscope
slide, approximately 5% of the total cholesterol remain
in the fixation bath and 15% in the filter paper used to
cover the agarose blocks before drying. These results
are consistent with data obtained by radiochemical
studies with [3H]cholesterol-labelled lipoproteins (in pre-
paration). In addition, 10 minutes for fixation are suffi-
cient to produce the visible opalescence of the lipopro-
teins. This opalescence, the albumin band prestained
with bromphenol blue, and a parallel pherogram per-
formed by lipid staining with Sudan black or another
lipid stain, make it possible to cut the fractions in a re-
producible manner. Usually, the 0-band is intensely
opaque; the pre- -band is more intense if the tri cyl-
glycerols are elevated; the upper limit of the α-band is
marked by the prestained albumin. It is advisable to cut
the fractions before drying the agarose blocks.
The agarose pieces can be transferred easily to the
centrifuge tubes by rolling them around a small glass
rod. In addition, the vibrations of the glass rod caused
by the vibrator enhance the dissolution of the agarose
with HCL After neutralization, the cholesterol is
measured by the modified enzymatic procedure.
Precision
The precision in the series was determined in four con- .
trol sera, five Type lib and in two type IV hyper-
lipidemic sera. The coefficients of variation (tab. 2) in-
clude the error of the electrophoresis procedure (31); in
addition, they are closely related to the cholesterol con-
tents in the corresponding lipoprotein fractions. There-
fore, the highest precision of < 4% is found in the 0-
lipoproteins of the controls and of the Type lib sera.
This is followed by the precision obtained for the β-
and pre- -lipoproteins of the Type IV sera (< 8%), by
the aJipoproteins in the control sera (< 12%), and by
the other lipoprotein fractions (16—36%). Accordingly,
the exact determination of cholesterol with the modified
lipoprotein method can be achieved in the 0-lipoproteins
of the controls; and of all the hyperlipidemic sera, and in
the pre-0-lipoproteins of the Type IV sera. The other data
have to be interpreted as an approximation because of
being measured near the detection limit.
Tab. 2. Precision in the series.
The percent distribution of cholesterol in different serum lipoprotein fractions was determined and the precision in the
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Fig. 1. Percent distribution of cholesterol and cholesterol concentrations in serum lipoproteins.
C = controls, LP = lipoproteins;
= jS-lipoproteins, : pre-0-lipoproteins, : o-lipoproteins.
Cholesterol content of serum lipoproteins
In preliminary studies, the distribution of cholesterol
between the lipoproteins was determined in sera repre-
senting different lipoprotein patterns (fig. 1). Prior to
agarose electrophoresis for the separation of the lipo-
protein fractions, the pheiiotypes of hyperlipidemia
were evaluated with the CORNING-EEL/IMA-micro-
electrophoresis system. The results obtained with this
system are comparable to those obtained with the
BOSCAMP-microphor system (fig. 2). The CORNING-
EEL system is highly suitable for large-scale studies
on the electrophoretic lipoprotein pattern in a given
population, e. g. in blood donors (30).
Figure 1 demonstrates that the percentage of the β-
lipoprotein-cholesterol is about the same in the controls
and in the Type lib sera (73 and 76%), it is slightly
higher in the Type II a sera (85%), and it is the lowest
in the Type IV sera (55-%). In the α-lippprpteins, the
highest percentage was found in the controls (17%). In
the pre- -lipoproteiris, the highest percentage was
measured in the Type IV seta (37%). These results are in
good agreement with data reported by other authors
who have used the ultracentrifuge or precipitation
methods for lipoprotein fractionation (tab. 3). As far




O R I G I N
Fig. 2. Lipoprotein pattern developed with the BOSCAMP-
microphor system (A) an<I with the CORNING-EEL/
IMA-micro-electrophoresis system (B).
the cholesterol concentrations are much lower, as in the
high density lipoproteins (HDL) (tab. 3). This difference
may be explained by the observation that the electro-
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Tab. 3. Synopsis of data reported by other investigators.
The cholesterol content was determined in density
classes prepared by the ultracentrifuge. The data are
expressed in mmol/1. LDL = low density lipoproteins,
VLDL = very low density lipoproteins, HDL = high
density lipoproteins. In those cases where the total
amount of the lipoproteins was noted, the Values found
by Ditschuneit (6) served for further calculations,
a = The LDL were prepared by precipitation.
Reference
Oncley et al. (1)
Furman et al. (2)
controls
prim. Hypercholesterolemia
Jones et al. (3)
controls plus hyperlipidemic
subjects
Wieland et al. (4)
controls






Rose et al. (7)
combined hyperlipidemia
Type IV hyperlipidemia




















































































phoretically separated albumin fraction carries roughly
the same amount of [3H]cholesterol, as compared to the
α-lipoproteins, if serum is incubated with [3H]cholesterol
prior to Use (in preparation). Presumably, this albumin
fraction contains α-lipoprotein cholesterol which is not
included in the data presented in Figure 1.
With the procedure described iii this report, the quanti-
tative determination of cholesterol in eiectrophoretic-
ally separated serum lipoproteins is possible. Parallel
studies on the distribution of cholesterol in serum lipo-
protein fractions separated by ultracentrifugation and
by electrpphoresis on agarose gel are planned. Summar-
izing, the following advantages of this new procedure
should be pointed out:
1. A very small amount of serum is required; this makes
the procedure suitable for pediatric problems and for
experiments with small animals.
2. The performance is simple, and the equipment re-
quired should be available in most of the laboratories.
3. Semiautomation and, therefore, large-scale sreening
seem to be possible.
4. Presumably, additional criteria for the differentiation
between Type lib and Type IV hyperlipidemia may
be elaborated.
Acknowledgement
The expert technical assistance of Mrs. Chr. Chucholl is grate-
fully acknowledged. I also wish to thank Mrs. G. Runge for her
help at the beginning of the studies; to Prof. H. Canzler, Divi-
sion of Nutrition, Medizinische Hochschule Hannover, for the
supply of pathological sera; to Dr. H. H indl, Institute of Nuclear
Medicine, Medizinische Hochschule Hannover, for measuring
the radioactive samples; and to Boehringer/Mannheim for the
generous supply of chemicals.
References
1. Oncley, J. L. (1963), in "Brain Lipids and Lipoproteins
and Leukodystrophies", p. 1-17 (Folchi-Pi, J. & Brown,
H. eds.) Eisevier, Amsterdam.
2. Furman, R. H., Alaupovic, P. & Gustafson, A. (1966),
in "Pathological and Clinical Aspects of Lipid Meta-
bolism", p. 5-10 (Schettler, G. & Sanwald, R., eds.)
Thieme-Verlag Stuttgart.
3. Jones, R. J., Cohen, L. & Dobrilovic, L. (1968), J.
Atheroscler. 8t 463-470.
4. Wieland, H. & Seidel, D. (1972), this Journal 10, 311-321.
5. Freedman, F., Buckley, G., Little, J. A. & Sebriafcova, M.
(1972), Clin. Biochem. 5, 83-87.
6. Ditschuneit, H. (1973), in "Die Lipoproteine des Blutes"
ρ. 31-41 (Ditschuneit, H., ed.), D. Steinkopf-Verlag.
7. Rose, H. G-, Kranz, P., Weinstock, M., Juliaiiq, J. & Haft,
J. I. (1974), Atherosclerosis 20, 51-64,
8. Hazzard, W. Rf, Goldstein, J. L·, Schrott, H. G.* Motulsky,
A. G. & Bierrnan, E. L. (1974), in "Atherosclerosis ffl",
p. 464-468, Proceedings of the Third International Sympo-
sium (Schettler, G. & Weizel, A., eds.) Springer-Verlag.
J. Clin. Chem. Oin. Biochem. / VoL 14,1976 /No. 5
Kupke: Enzymatic determination of cholesterol in serum lipoproteins 223
9. Klemens, U. H.» Knöchel, W. & von Lewis of Menar, P.
(1974) in "Serumproteine", p. 125-132 (Englhardt, A.
& Lommel, H., eds.) Verlag Chemie, Weinheim/Bergstr.
10. Fredrickson, D. S. & Levy, R. I. (1972), in "The Meta-
bolic Basis of Inherited Diseases'*, p. 545-614 (Stanbury,
J. B., Wyngaarden, J. B. & Fredrickson, D. S., eds.) McGraw-
Hill Book Comp.
11. Fredrickson, D. S. (1974) in "Lipid Metabolism, Obesity, and
Diabetes Mellitus: Impact upon Atherosclerosis", p. 2-6,
Intern. Symposium April 1972 (Greten, H., Levine, R.,
Pfeiffer, E. F. & Renold, A. E., eds.), G. Thieme Publ.
Stuttgart.
12. Assmann, G. & Fredrickson, D. S. (1974), in "Athero-
sclerosis III", p. 641-651, Proceedings of the Third Intern.
Symposium (Schettler, G. & Weizel, A., eds.) Springer-
Verlag.
13. Oncley, J. L., Walton, K. W. & Cornwell, D. G. (1957),
J. Amer. Chem. Soc. 79,4666-4671.
14. Burstein, Par M. & Samaille, J. (1959), Ann. BioL Clin.,
Annee XVII, 23-33.
15. Amenta, J. S. & Waters, L. L. (1960), Yale J. Biol. Med. 33,
112-119.
16. Stokes, R. P., Jacobsson, A. & Walton, K. W. (1967), J.
Atherosclerosis Res. 7,187-196.
17. Berenson, G. S., Srinivasan, S. R., Pargaonkar, P. S.,
Radhakrishnamurthy, B. & Dalferes, E. R. (1972), Clin.
Chem. 18,1463-1467.
18. Searcy, R., Colaianni, W., Young, E., Drnec, J. & Magoc, T.
(1972), din. Chim. Acta 38, 291-300.
19. Lopez-s, A., Vial, R., Baiart, L. & Arroyave, G. (1974),
Atherosclerosis 20,1.-9.
20. Fredrickson, D. S. (1972), Modern Concepts of Cardiovas-
cular Disease XLI, 31-36.
21. Phillips, G. B. & Wille, L. E. (1973), Clin. Chim. Acta 49,
153-160.
22. Magnani, H. N. & Alaupovic, P. (1972), Clin. Chim. Acta
5$, 405-411.
23. Kupke, I. R. (1972), J. Molecul. Cellul. Cardiol. 4, 255
-268.
24. Ritland, St. (1974), din. Chim. Acta 55, 359-366.
25. Kahlke, W. (1972), KHA, Heft 8, 470-480.
26. Kahlke, W. (1974), in "Serumproteine", p. 105-110
(Englhardt, A. & Lommel, H., eds.) Verlag Chemie, Wein-
heim, Bergstr.
27. Roeschlau, P., Bernt, E. & Gruber, W. (1974), this Journal
12, 403-407.
28. Fredrickson, D. S., Levy, R. I. & Lees, R. S. (1967), New
England J. Med. 276, 34-44, 94-103,148-156, 215-224,
273-281.
29. Beaumont, J. L., Carlson, L. A., Cooper, G. R., Fejfar, Z.,
Fredrickson, D. S. & Strasser, T. (1970), Bull Wld Hlth Org.
43, 891-915.
30. Kupke, I. R., Stangl, W. & Papastvrou, St., 14th Congress of
the Intern. Society of Blood Transfusion, July 27—August 1,
Helsinki 1975.
31. Houtsmuller, A. J. (1969), "Agarose-Gel Electrophoresis of
Lipoproteins", van Gorcum and Comp., Prakke, N. V. -
Dr. H. J. & Prakke, H.M.G., Assen.






J. Clin. Chem. Clin. Biochem. / VoL 14,1976 / No. 5 16·

